The U.S. government will make 400 million non-surgical N95 masks from its strategic national stockpile available for free to the public starting next week, a White House official said, marking the Biden administration’s latest effort to help curb the COVID-19 pandemic.
CVS Health Corp. will shut about 900 stores over the next three years as the company tries to adapt to changing consumer preferences by pivoting to new store formats that offer more health services.
CVS Health Corp. on November 3 said the company’s adjusted profit target for 2022 should largely meet Wall Street estimates, with volatile medical costs in its health insurance unit expected to stabilize after the Covid-19 crisis drove them up during 2021.
CVS Health Corp. said on Sept. 20 the company would fill as many as 25,000 clinical and retail jobs ahead of the flu season and as the United States prepares to administer booster Covid-19 vaccine shots.
Cigna Corp. said on Aug. 26 the company would now sell health insurance plans on online marketplaces created by the Affordable Care Act (ACA), popularly known as Obamacare, in three new U.S. states and 93 new counties.
Walgreens Boots Alliance Inc. said on Aug. 4 the drugstore chain had administered more than 29 million Covid-19 vaccines at its stores so far, led by a surge in parts of the United States that had lagged in vaccinations.
Pharmacy operators Walgreens Boots Alliance Inc., CVS Health Corp., Rite Aid Corp. and Walmart Inc. agreed to pay a combined $26 million to settle claims by two New York counties that they fueled an opioid addiction epidemic.
CVS Health announced a new Clinical Trial Services business that brings together innovation and experience, driving greater access to clinical trials across the communities the company serves and creating a more efficient, convenient experience to improve participant retention and research effectiveness.
CVS Health Corp. said on April 19 it will offer three over-the-counter Covid-19 tests at drugstores as well as online, expanding access to home testing in the United States.
Covid-19 vaccine makers told Congress on Feb. 23 that U.S. supplies should surge in the coming weeks due to manufacturing expansions and new vaccine authorizations.